TRANSNATIONALE.ORG
SEARCH  web site
COMPANIES
Discover the reality of companies and brands !

Ivax Corp

Headquarters : 4400 Biscayne Blvd Miami, FL 33137 United States of America United States of America
Job offers, investor relations : web www.ivax.com tel. 305-575-6000 email: ir@ivax.com stock : IVX analytics

Brands

name
click to compare prices
» Shop local, ethical and at the best price on Ethishop
« ETHICAL » RATING OF IVAX CORP , group Teva Pharmaceutical Industries Ltd. and subsidiaries
[click on the rating for the method or on the number for the data]
Fraud 3 Offshore 2 Sales 5 Bn $.€ /year Profit 3 Bn $.€ /1998 Wage 291 *min.

shareholdercountry%source
Teva Pharmaceutical Industries Ltd.Israel100Les Echos
» More shareholders of Ivax Corp
subsidiarycountry%source
Laboratorio Chile S.A. Chile100Company
» More subsidiaries of Ivax Corp

  • Environmental impact

  • Human impact

year name
photo position; compensation
source
2001Beier, Thomas E
See the photo of: Beier, Thomas E Chief Financial Officer;
Company
2001Flanzraich, Neil
See the photo of: Flanzraich, Neil Chairman; salary: 1 million US$;
Company
2001Frost, Philip
See the photo of: Frost, Philip Chief Executive Officer; salary: 1.2 million US$;
Company
2001Hsiao, Jane
See the photo of: Hsiao, Jane Vice-president; salary: 1 million US$;
Company
year
employees
<>
social impact : country
source
2002
8360
Company
2001
8175
Company
year
employees
<>
social impact : country
source
 2 informations, access to subscribers

  • Lobbying & corruption

  • Subsidy

  • Advertising & marketing

yearfinancial misdemeanorsalesincome source
2005 Its subsidiary, Norton Healthcare, is investigated by the UK NHS for alleged price fixing of two drugs: anticoagulant warfarin and penicillin-based antibiotics.     The Telegraph
2002   1.20.12   billion US$Company
2002 Alleged cartel in blood-thinning drug warfarin market: prices and levels of supply reviewed or revised and discussion of price-fixing arrangements overseas, discussed carving up their combined customer base across UK to reduce or eliminate competition.     The Guardian
2001   1.220.24   billion US$Company
2000   0.790.13   billion US$Company
1999   0.660.07   billion US$Company
yearfinancial misdemeanorsalesincomeassetsbuybacksource
 6 informations, access to subscribers

Your contributions (0)

Bookmark and Share    en español  en français  in italiano
translate this page in arabic chinese dutch german japanese korean russian
Legal notice © T&C 1999-2009